Abstract
Purpose
To compare the mean deviation (MD) between monocular and integrated binocular visual field (BVF).
Methods
Thirty-six patients with glaucoma in at least 1 eye were recruited for the present study. Seventy-two threshold sensitivities of the BVF were obtained without additional visual field test by the Best Location and Binocular Summation methods using the 2 monocular visual fields of central 30 o. The MD of the BVF was obtained by comparison to the value distribution in the age-matched population with normal BVF. After defining the better eye with the better MD value from the 2 eyes, comparison of the MDs between individual eyes and the integrated BVF were assessed. In addition, the MDs be-tween the integrated BVF and actual BVF were compared in 11 patients.
Results
In patients with a mean age of 58.7 years, the MD of the better eye was -2.3 dB, and the worse eye was -4.9 dB (p < 0.01). There was a significant difference between the 2 MDs derived from Best Location and Binocular Summation (-1.7 and -2.0 dB, respectively p = 0.045). The MDs according to BVF more improved than the better eye (p < 0.01 for both). There was no significant difference in MDs between integrated BVF and actual BVF (-1.9 vs -2.0, -2.3 vs -2.0, re-spectively p > 0.1).
References
1. Kass MA, Heuer DK, Higginbotham EJ. . The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:701–13.
2. Miglior S, Zeyen T, Pfeiffer N. . Results of the European Glaucoma Prevention Study. Ophthalmology. 2005; 112:366–75.
3. Gupta N, Krishnadev N, Hamstra SJ, Yücel YH. Depth perception deficits in glaucoma suspects. Br J Ophthalmol. 2006; 90:979–81.
4. Ramulu PY, West SK, Munoz, B. . Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology. 2009; 116:1846–53.
5. McGwin G Jr, Xie A, Mays A. . Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:4437–41.
6. Patino CM, McKean-Cowdin R, Azen SP. . Central and periph-eral visual impairment and the risk of falls and falls with injury. Ophthalmology. 2010; 117:199–206.
7. Gutierrez P, Wilson MR, Johnson C. . Influence of glaucoma-tous visual field loss on health-related quality of life. Arch Ophthalmol. 1997; 115:777–84.
8. Janz NK, Wren PA, Lichter PR. . Quality of life in newly diag-nosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001; 108:887–97.
9. McKean-Cowdin R, Wang Y, Wu J. . Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008; 115:941–8.e1.
10. Parrish RK 2nd, Gedde SJ, Scott IU. . Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997; 115:1447–55.
11. van Gestel A, Webers CA, Beckers HJ. . The relationship be-tween visual field loss in glaucoma and health-related qual-ity-of-life. Eye (Lond). 2010; 24:1759–69.
12. Varma R, Wu J, Chong K. . Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology. 2006; 113:1846–53.
13. Friedman DS, Freeman E, Munoz B. . Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007; 114:2232–7.
14. Owen VM, Crabb DP, White ET. . Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness. Invest Ophthalmol Vis Sci. 2008; 49:2449–55.
15. Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002; 43:1059–67.
16. Crabb DP, Viswanathan AC, McNaught AI. . Simulating bin-ocular visual field status in glaucoma. Br J Ophthalmol. 1998; 82:1236–41.
17. Nelson-Quigg JM, Cello K, Johnson CA. Predicting binocular vis-ual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci. 2000; 41:2212–21.
18. Crabb DP, Fitzke FW, Hitchings RA, Viswanathan AC. A practical approach to measuring the visual field component of fitness to drive. Br J Ophthalmol. 2004; 88:1191–6.
19. Legge GE. Binocular contrast summation–II. Quadratic summation. Vision Res. 1984; 24:385–94.
20. Anderson DR. The single field printout with Statpac analysis. Kist K, ed. Automated Static Perimetry. St. Louis: MO Mosby;1992; 84.
22. Jampel HD. Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001; 99:301–17.
23. Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998; 96:753–812.
25. Meese TS, Georgeson MA, Baker DH. Binocular contrast vision at and above threshold. J Vis. 2006; 6:1224–43.
26. Simpson WA, Manahilov V, Shahani U. Two eyes: square root 2 better than one? Acta Psychol (Amst). 2009; 131:93–8.
Table 1.
Patient group | Control group | p-value* | |
---|---|---|---|
Number of included subjects | 36 | 30 | |
Age (year) | 58.7 ± 8.9 | 59.3 ± 10.2 | 0.194 |
Sex (F/M) (n (%)) | 19 (52.8)/17 (47.2) | 17 (56.7)/13 (43.3) | 0.282 |
IOP (mm Hg)† | 14.8 ± 3.8 | 15.0 ± 2.5 | 0.420 |
Follow-up (year) | 3.8 ± 1.3 | 1.2 ± 0.4 | <0.01 |
Total number of VF (pairs) | 72 (36) | 60 (30) | |
MD of right VF, dB‡ | -4.4 ± 3.5 (-5.9, -3.1, -1.9) | -0.3 ± 1.3 (-1.1, -0.3, 0.7) | <0.01 |
MD of left VF, dB‡ | -2.9 ± 2.4 (-4.1, -1.9, -1.7) | -0.4 ± 1.5 (-1.3, -0.6, 1.0) | <0.01 |
Table 2.
Mean deviation, dB* | p-value† | p-value‡ | |
---|---|---|---|
Right VFs | -4.4 ± 3.5 (-5.9, -3.1, -1.9) | <0.01 | <0.01 |
Left VFs | -2.9 ± 2.4 (-4.1, -1.9, -1.7) | <0.01 | <0.01 |
BVF by best location | -1.7 ± 1.4 (-2.5, -1.5, -0.9) | 0.045 | |
BVF by binocular summation | -2.0 ± 1.6 (-2.9, -1.9, -1.0) | 0.045 | |
The better eye | -2.3 ± 2.0 (-3.0, -1.9, -1.5) | 0.035 | <0.01 |
The worse eye | -4.9 ± 3.4 (-7.0, -3.6, -2.2) | <0.01 | <0.01 |
Table 3.
Mean deviation, dB* | p-value† | |
---|---|---|
Actual BVF | -2.0 ± 2.7 (-4.5, -2.0, 1.0) | |
BVF by best location | -1.9 ± 2.4 (-4.3, -2.1, 0.4) | 0.858 |
BVF by binocular summation | -2.3 ± 2.7 (-5.1, -2.5, 0.3) | 0.172 |
Table 4.
Mean deviation, dB* | p-value† | p-value‡ | |
---|---|---|---|
Patients with glaucoma at both eyes (n = 14) | |||
BVF by best location | -2.3 ± 1.6 (-3.5, -2.1, -1.1) | <0.01 | |
BVF by binocular summation | -2.7 ± 1.7 (-3.7, -2.4, -1.6) | <0.01 | |
The better eye | -3.7 ± 2.4 (-5.6, -3.4, -1.9) | 0.036 | 0.041 |
The worse eye | -6.7 ± 3.6 (-8.8, -5.9, -3.5) | <0.01 | <0.01 |
Patients with glaucoma at only one eye (n = 22) | |||
BVF by best location | -1.3 ± 1.3 (-1.9, -1.2, -0.7) | 0.038 | |
BVF by binocular summation | -1.4 ± 1.1 (-1.9, -1.7, -0.4) | 0.038 | |
The better eye | -1.5 ± 1.3 (-2.2, -1.2, -0.8) | <0.01 | 0.096 |
The worse eye | -3.8 ± 2.7 (-5.1, -2.6, -2.0) | <0.01 | <0.01 |